Here, we are going to share Marksans Pharma Share Price Target 2025, 2026, 2027, 2028, 2030, 2035, 2040 on the basis of its fundamental and technical analysis.
Marksans Pharma Ltd is a midcap pharmaceutical company based in India, focused on the manufacturing and marketing of generic pharmaceutical formulations.
It serves markets like the U.S., UK, Australia, and other emerging regions. The company specializes in oral solid dosages, liquids, and soft gel capsules, with a strong emphasis on regulated markets.
Marksans Pharma Share Key Information
| Company Name | Marksans Pharma Ltd. |
| Headquarters | India |
| Sectors | Pharmaceuticals & Drugs |
| Market Cap | ₹ 15,160.59 Cr. |
| No. of Shares | 45.32 Cr. |
| Book Value | ₹ 28.49 |
| Dividend Yield | 0.19% |
| ROCE | 14.81% |
| ROE | 11.46% |
| Face Value | ₹ 1 |
| Sales Growth | 30.23% |
| Profit Growth | 30.03% |
Marksans Pharma Business Sector
Generic Formulations: Manufacturing oral solids, soft gel capsules, and liquids.
International Markets: Exporting to the U.S., UK, Europe, and emerging regions.
Therapeutic Drugs: Offering OTC and prescription medicines for chronic and acute conditions.
Board Members
- Mark Saldanha – Managing Director
- Sandra Saldanha – Whole-Time Director
- Dr. Vinay G. Nayak – Whole-Time Director
- Naresh B. Wadhwa – Independent Director
- Seetharama R. Buddharaju – Independent Director
- Ajay S. Joshi – Independent Director
Marksans Pharma Share Quarterly Results
| PARTICULARS | Jun 2024 | Sep 2024 |
|---|---|---|
| Net Sales | 254.53 | 308.63 |
| Total Expenditure | 213.26 | 256.35 |
| Operating Profit | 41.27 | 52.27 |
| Other Income | 8.15 | 31.36 |
| Interest | 0.28 | 0.28 |
| Depreciation | 6.84 | 7.02 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 42.30 | 76.34 |
| Tax | 10.28 | 13.13 |
| Profit After Tax | 32.02 | 63.20 |
| Adjusted EPS (Rs) | 0.71 | 1.39 |
Marksans Pharma Company Profits and Losses
| PARTICULARS | Mar 2023 | Mar 2024 |
|---|---|---|
| Net Sales | 655.20 | 853.27 |
| Total Expenditure | 582.23 | 713.34 |
| Operating Profit | 72.97 | 139.94 |
| Other Income | 79.41 | 62.07 |
| Interest | 3.61 | 0.99 |
| Depreciation | 16.74 | 29.13 |
| Exceptional Items | 0 | 0 |
| Profit Before Tax | 132.04 | 171.89 |
| Tax | 29.17 | 38.13 |
| Net Profit | 102.87 | 133.76 |
| Adjusted EPS (Rs.) | 2.27 | 2.95 |
Marksans Pharma Share Price Target 2025-2040
| Year | Initial Target | Year-End Target |
|---|---|---|
| 2025 | ₹317 | ₹364 |
| 2026 | ₹364 | ₹411 |
| 2027 | ₹412 | ₹459 |
| 2028 | ₹460 | ₹507 |
| 2029 | ₹508 | ₹554 |
| 2030 | ₹557 | ₹592 |
| 2035 | ₹912 | ₹998 |
| 2040 | ₹1310 | ₹1499 |
Marksans Pharma Share Price Target 2025
| Year/Month | Predicted Target |
|---|---|
| January 2025 | ₹317 |
| February 2025 | ₹316 |
| March 2025 | ₹320 |
| April 2025 | ₹326 |
| May 2025 | ₹327 |
| June 2025 | ₹335 |
| July 2025 | ₹343 |
| August 2025 | ₹348 |
| September 2025 | ₹351 |
| October 2025 | ₹358 |
| November 2025 | ₹359 |
| December 2025 | ₹364 |
Based on the 2025 forecast, the initial target of Marksans Pharma share can could be ₹317 and by the end of the year, the share price target is estimated to reach ₹364.
Marksans Pharma Share Price Target 2026
| Year/Month | Predicted Target |
|---|---|
| January 2026 | ₹364 |
| February 2026 | ₹367 |
| March 2026 | ₹368 |
| April 2026 | ₹374 |
| May 2026 | ₹375 |
| June 2026 | ₹383 |
| July 2026 | ₹391 |
| August 2026 | ₹397 |
| September 2026 | ₹405 |
| October 2026 | ₹407 |
| November 2026 | ₹410 |
| December 2026 | ₹411 |
Based on the 2026 forecast, the initial target of Marksans Pharma share can could be ₹364 and by the end of the year, the share price target is estimated to reach ₹411.
Marksans Pharma Share Price Target 2027
| Year/Month | Predicted Target |
|---|---|
| January 2027 | ₹412 |
| February 2027 | ₹417 |
| March 2027 | ₹425 |
| April 2027 | ₹429 |
| May 2027 | ₹431 |
| June 2027 | ₹438 |
| July 2027 | ₹445 |
| August 2027 | ₹453 |
| September 2027 | ₹451 |
| October 2027 | ₹454 |
| November 2027 | ₹458 |
| December 2027 | ₹459 |
Based on the 2027 forecast, the initial target of Marksans Pharma share can could be ₹412 and by the end of the year, the share price target is estimated to reach ₹459.
Marksans Pharma Share Price Target 2028
| Year/Month | Predicted Target |
|---|---|
| January 2028 | ₹460 |
| February 2028 | ₹461 |
| March 2028 | ₹463 |
| April 2028 | ₹470 |
| May 2028 | ₹472 |
| June 2028 | ₹478 |
| July 2028 | ₹487 |
| August 2028 | ₹493 |
| September 2028 | ₹501 |
| October 2028 | ₹503 |
| November 2028 | ₹506 |
| December 2028 | ₹507 |
Based on the 2028 forecast, the initial target of Marksans Pharma share can could be ₹460 and by the end of the year, the share price target is estimated to reach ₹507.
Marksans Pharma Share Price Target 2029
| Year/Month | Predicted Target |
|---|---|
| January 2029 | ₹508 |
| February 2029 | ₹509 |
| March 2029 | ₹511 |
| April 2029 | ₹518 |
| May 2029 | ₹519 |
| June 2029 | ₹526 |
| July 2029 | ₹535 |
| August 2029 | ₹540 |
| September 2029 | ₹549 |
| October 2029 | ₹550 |
| November 2029 | ₹551 |
| December 2029 | ₹554 |
Based on the 2029 forecast, the initial target of Marksans Pharma share can could be ₹508 and by the end of the year, the share price target is estimated to reach ₹554.
Marksans Pharma Share Price Target 2030
| Year/Month | Predicted Target |
|---|---|
| January 2030 | ₹557 |
| February 2030 | ₹559 |
| March 2030 | ₹565 |
| April 2030 | ₹567 |
| May 2030 | ₹569 |
| June 2030 | ₹571 |
| July 2030 | ₹573 |
| August 2030 | ₹578 |
| September 2030 | ₹579 |
| October 2030 | ₹581 |
| November 2030 | ₹583 |
| December 2030 | ₹592 |
Based on the 2030 forecast, the initial target of Marksans Pharma share can could be ₹557 and by the end of the year, the share price target is estimated to reach ₹592.
Marksans Pharma Share Price Target 2035
| Year/Month | Predicted Target |
|---|---|
| January 2035 | ₹912 |
| April 2035 | ₹956 |
| July 2035 | ₹963 |
| October 2035 | ₹986 |
| December 2035 | ₹998 |
Based on the 2035 forecast, the initial target of Marksans Pharma share can could be ₹912 and by the end of the year, the share price target is estimated to reach ₹998.
Marksans Pharma Share Price Target 2040
| Year/Month | Predicted Target |
|---|---|
| January 2040 | ₹1310 |
| April 2040 | ₹1389 |
| July 2040 | ₹1425 |
| October 2040 | ₹1477 |
| December 2040 | ₹1499 |
Based on the 2040 forecast, the initial target of Marksans Pharma share can could be ₹1310 and by the end of the year, the share price target is estimated to reach ₹1499.
Marksans Pharma Shareholding Pattern
| Terms | Percentage |
|---|---|
| Promoters | 43.87% |
| FIIs | 21.31% |
| DIIs | 4.1% |
| Others | 0% |
| Public | 30.71% |
Marksans Pharma Company Competitors
- Neuland Laboratories
- Jubilant Pharmova
- Astrazeneca Pharma I
- Caplin Point Lab
- Indegene
- Granules India
- Sanofi India
- Glenmark Life Science
- Strides Pharma Science
Bull Case of Marksans Pharma (Reasons to Invest)
Global Market Access: The company’s significant presence in regulated markets positions it favorably for consistent revenue growth.
Strong Fundamentals: Positive technical indicators and a healthy balance sheet further bolster investor confidence.
Bear Case of Marksans Pharma (Risks Involved)
Poor Revenue Growth: Over the last three years, the company’s sales growth has been a disappointing 12.48%.
High EV/EBITDA: The company is now trading at a high EV/EBITDA ratio of 62.94.
Marksans Pharma Share Price Target: FAQ
What will be the target of Marksans Pharma Share for the year 2025?
By the end of the year 2025, its share price can reach ₹364.
What will be the target of Marksans Pharma Share for the year 2026?
By the end of the year 2026, its share price can reach ₹411.
What will be the target of Marksans Pharma Share for the year 2027?
By the end of the year 2027, its share price can reach ₹459.
What will be the target of Marksans Pharma Share for the year 2028?
By the end of the year 2028, its share price can reach ₹507.
What will be the target of Marksans Pharma Share for the year 2029?
By the end of the year 2029, its share price can reach ₹554.
What will be the target of Marksans Pharma Share for the year 2030?
By the end of the year 2030 its share price can reach ₹592.
What is the Current market cap of Marksans Pharma company?
At present the market cap of this company is ₹ 15,160.59 Cr.
What is the NSE symbol of Marksans Pharma company?
The symbol of this company in NSE exchange is MARKSANS.
What is the BSE symbol of Marksans Pharma company?
The symbol of this company in BSE exchange is 524404 .
